regulatory

  • Why new FDA social media guidance will not be a magic pill for global pharma

    by - May 29, 2015
    For many years, the pharmaceutical industry has been crying out for improved guidance on its use of social media from the Food and Drug Administration (FDA), arguing that current regulations have not kept up with the...
  • Managing a Social Media Crisis

    by - Sep 15, 2011
    Background In 2011, the organizers of e-Patient Connections Conference approached Creation Healthcare’s Founder, Daniel Ghinn, after the company’s analysis into recent social media crises in the healthcare arena. They asked if Daniel would prepare a workshop...
  • Handling a Social Media Crisis: Lessons From The Real World

    by - Aug 31, 2011
    If a potential social media PR disaster happens to your organization, do you know how you would respond? At e-Patient Connections in Philadelphia, Creation Healthcare’s CEO Daniel Ghinn will lead a practical workshop that will equip...
  • Introduction to Digital Governance

    by - Aug 18, 2011
    In the pharmaceutical and medical device industries, control of digital activities – including social media – is paramount to avoid fines and ensure that proper strategies and structures are in place to maximise commercial opportunities. A...
  • Is failure an option?

    by - Jun 17, 2011
    No one wants to be wrong; ever. As much as there are trendy business mantras such as ‘Fail Fast’ which apparently encourage failure (as long as you learn quickly), it somehow just doesn’t translate to the...
  • A Practical Guide to Interpreting PMCPA guidance

    by - Apr 13, 2011
    It was ironically only a couple of weeks ago that Creation Healthcare published a piece about “Healthcare engagement in the absence of regulatory guidance”. In that article, I made the point that “specific social media guidance...
  • Healthcare engagement in the absence of regulatory guidance

    by - Mar 23, 2011
    In early March 2011, at a pharmaceutical marketing conference in Munich, Heather Simmonds of the PMCPA gave very much the same perspective on UK and European regulatory guidelines that she has for the past few years....
Subscribe free to receive monthly eJournal edition